COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies.
Publication
, Journal Article
Monk, BJ; Coleman, RL; Moore, KN; Herzog, TJ; Secord, AA; Matulonis, UA; Slomovitz, BM; Guntupalli, SR; O'Malley, DM
Published in: Gynecol Oncol
July 2020
• The pandemic COVID-19 requires alternative methods and thinking to keep healthcare professionals and patients safe. • In COVID-19 hot spots, oral therapies may be viable alternatives to intravenous therapies for treatment of ovarian cancer. • Minimizing patient visits to hospitals and cancer clinics may help mitigate the spread of SARS-CoV-2.
Duke Scholars
Published In
Gynecol Oncol
DOI
EISSN
1095-6859
Publication Date
July 2020
Volume
158
Issue
1
Start / End Page
34 / 36
Location
United States
Related Subject Headings
- SARS-CoV-2
- Poly(ADP-ribose) Polymerase Inhibitors
- Pneumonia, Viral
- Pandemics
- Ovarian Neoplasms
- Organoplatinum Compounds
- Oncology & Carcinogenesis
- Infusions, Intravenous
- Humans
- Female
Citation
APA
Chicago
ICMJE
MLA
NLM
Monk, B. J., Coleman, R. L., Moore, K. N., Herzog, T. J., Secord, A. A., Matulonis, U. A., … O’Malley, D. M. (2020). COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies. Gynecol Oncol, 158(1), 34–36. https://doi.org/10.1016/j.ygyno.2020.04.703
Monk, Bradley J., Robert L. Coleman, Kathleen N. Moore, Thomas J. Herzog, Angeles Alvarez Secord, Ursula A. Matulonis, Brian M. Slomovitz, Saketh R. Guntupalli, and David M. O’Malley. “COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies.” Gynecol Oncol 158, no. 1 (July 2020): 34–36. https://doi.org/10.1016/j.ygyno.2020.04.703.
Monk BJ, Coleman RL, Moore KN, Herzog TJ, Secord AA, Matulonis UA, et al. COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies. Gynecol Oncol. 2020 Jul;158(1):34–6.
Monk, Bradley J., et al. “COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies.” Gynecol Oncol, vol. 158, no. 1, July 2020, pp. 34–36. Pubmed, doi:10.1016/j.ygyno.2020.04.703.
Monk BJ, Coleman RL, Moore KN, Herzog TJ, Secord AA, Matulonis UA, Slomovitz BM, Guntupalli SR, O’Malley DM. COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies. Gynecol Oncol. 2020 Jul;158(1):34–36.
Published In
Gynecol Oncol
DOI
EISSN
1095-6859
Publication Date
July 2020
Volume
158
Issue
1
Start / End Page
34 / 36
Location
United States
Related Subject Headings
- SARS-CoV-2
- Poly(ADP-ribose) Polymerase Inhibitors
- Pneumonia, Viral
- Pandemics
- Ovarian Neoplasms
- Organoplatinum Compounds
- Oncology & Carcinogenesis
- Infusions, Intravenous
- Humans
- Female